Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:49 UTC |
---|
Update Date | 2022-03-07 02:51:38 UTC |
---|
HMDB ID | HMDB0014488 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Protriptyline |
---|
Description | Protriptyline hydrochloride is a dibenzocycloheptene-derivative tricyclic antidepressant (TCA). TCAs are structurally similar to phenothiazines. They contain a tricyclic ring system with an alkyl amine substituent on the central ring. In non-depressed individuals, protriptyline does not affect mood or arousal, but may cause sedation. In depressed individuals, protriptyline exerts a positive effect on mood. TCAs are potent inhibitors of serotonin and norepinephrine reuptake. In addition, TCAs down-regulate cerebral cortical β-adrenergic receptors and sensitize post-synaptic serotonergic receptors with chronic use. The antidepressant effects of TCAs are thought to be due to an overall increase in serotonergic neurotransmission. TCAs also block histamine H1 receptors, α1-adrenergic receptors and muscarinic receptors, which accounts for their sedative, hypotensive and anticholinergic effects (e.g. blurred vision, dry mouth, constipation, urinary retention), respectively. See toxicity section below for a complete listing of side effects. Protriptyline may be used for the treatment of depression. |
---|
Structure | CNCCCC1C2=CC=CC=C2C=CC2=CC=CC=C12 InChI=1S/C19H21N/c1-20-14-6-11-19-17-9-4-2-7-15(17)12-13-16-8-3-5-10-18(16)19/h2-5,7-10,12-13,19-20H,6,11,14H2,1H3 |
---|
Synonyms | Value | Source |
---|
3-(5H-Dibenzo[a,D]cyclohepten-5-yl)-N-methyl-1-propanamine | ChEBI | 5-(3-Methylaminopropyl)-5H-dibenzo[a,D]cycloheptene | ChEBI | 7-(3-Methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene | ChEBI | Amimetilina | ChEBI | N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propanamine | ChEBI | N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propylamine | ChEBI | Protryptyline | HMDB | Odyssey brand OF protriptyline hydrochloride | HMDB | Hydrochloride, protriptyline | HMDB | Vivactil | HMDB | Protriptyline hydrochloride | HMDB |
|
---|
Chemical Formula | C19H21N |
---|
Average Molecular Weight | 263.3767 |
---|
Monoisotopic Molecular Weight | 263.167399677 |
---|
IUPAC Name | methyl(3-{tricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,9,11,13-heptaen-2-yl}propyl)amine |
---|
Traditional Name | protriptyline |
---|
CAS Registry Number | 438-60-8 |
---|
SMILES | CNCCCC1C2=CC=CC=C2C=CC2=CC=CC=C12 |
---|
InChI Identifier | InChI=1S/C19H21N/c1-20-14-6-11-19-17-9-4-2-7-15(17)12-13-16-8-3-5-10-18(16)19/h2-5,7-10,12-13,19-20H,6,11,14H2,1H3 |
---|
InChI Key | BWPIARFWQZKAIA-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as dibenzocycloheptenes. Dibenzocycloheptenes are compounds containing a dibenzocycloheptene moiety, which consists of two benzene rings connected by a cycloheptene ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Dibenzocycloheptenes |
---|
Sub Class | Not Available |
---|
Direct Parent | Dibenzocycloheptenes |
---|
Alternative Parents | |
---|
Substituents | - Dibenzocycloheptene
- Aralkylamine
- Secondary amine
- Secondary aliphatic amine
- Organic nitrogen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Organonitrogen compound
- Amine
- Aromatic homopolycyclic compound
|
---|
Molecular Framework | Aromatic homopolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 169 - 171 °C (protriptyline hydrochloride) | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.00023 g/L | Not Available | LogP | 4.7 | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Protriptyline,1TMS,isomer #1 | CN(CCCC1C2=CC=CC=C2C=CC2=CC=CC=C21)[Si](C)(C)C | 2511.8 | Semi standard non polar | 33892256 | Protriptyline,1TMS,isomer #1 | CN(CCCC1C2=CC=CC=C2C=CC2=CC=CC=C21)[Si](C)(C)C | 2584.1 | Standard non polar | 33892256 | Protriptyline,1TMS,isomer #1 | CN(CCCC1C2=CC=CC=C2C=CC2=CC=CC=C21)[Si](C)(C)C | 3281.9 | Standard polar | 33892256 | Protriptyline,1TBDMS,isomer #1 | CN(CCCC1C2=CC=CC=C2C=CC2=CC=CC=C21)[Si](C)(C)C(C)(C)C | 2724.0 | Semi standard non polar | 33892256 | Protriptyline,1TBDMS,isomer #1 | CN(CCCC1C2=CC=CC=C2C=CC2=CC=CC=C21)[Si](C)(C)C(C)(C)C | 2808.1 | Standard non polar | 33892256 | Protriptyline,1TBDMS,isomer #1 | CN(CCCC1C2=CC=CC=C2C=CC2=CC=CC=C21)[Si](C)(C)C(C)(C)C | 3391.0 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Protriptyline GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-9040000000-6498574fa1f4eead1816 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Protriptyline GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Protriptyline GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | MS | Mass Spectrum (Electron Ionization) | splash10-006x-8910000000-ec599ee02d998905757e | 2014-09-20 | Not Available | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Protriptyline 10V, Positive-QTOF | splash10-03e9-0090000000-2ab870bf797378caf1c5 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Protriptyline 20V, Positive-QTOF | splash10-01q9-2190000000-b7468843989ba53316aa | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Protriptyline 40V, Positive-QTOF | splash10-052f-8890000000-d9505145b3d35ed27be8 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Protriptyline 10V, Negative-QTOF | splash10-03di-0090000000-13fe8faae8c2bed47e30 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Protriptyline 20V, Negative-QTOF | splash10-03di-1090000000-8781e71c0e0ae6ea19be | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Protriptyline 40V, Negative-QTOF | splash10-001l-5490000000-349b95c342d47d80f512 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Protriptyline 10V, Negative-QTOF | splash10-03di-0090000000-330f29be739abf456d25 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Protriptyline 20V, Negative-QTOF | splash10-03di-0090000000-45344afe501cffed83b8 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Protriptyline 40V, Negative-QTOF | splash10-0j6u-0590000000-16a1cb7e0b6aa13171c8 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Protriptyline 10V, Positive-QTOF | splash10-03di-0090000000-0f92e6ab1c1e69d00ae5 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Protriptyline 20V, Positive-QTOF | splash10-03di-0090000000-049efc86fef6b36591c4 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Protriptyline 40V, Positive-QTOF | splash10-0a4l-1690000000-6edf1174a6d682928acd | 2021-09-24 | Wishart Lab | View Spectrum |
|
---|